Literature DB >> 11870425

Preoperative local MRI-staging of patients with a suspected pancreatic mass.

U Fischer1, R Vosshenrich, O Horstmann, H Becker, B Salamat, F Baum, E Grabbe.   

Abstract

The aim of this study was to define the value of MRI of the pancreas for preoperative local staging of patients with a suspected pancreatic mass. Ninety-four patients (41 women, 53 men; age range 32-87 years) with a suspected pancreatic tumor underwent preoperative staging with MRI on a 1.5-T system. The MRI protocol included breath-hold MR cholangiopancreatography in turbo spin-echo technique, biphasic contrast-enhanced 3D MR angiography, and MRI of the upper abdomen with breath-hold T2-weighted half-Fourier acquired single-shot turbo spin-echo and T1-weighted fast-low-angle-shot (pre- and postcontrast) sequences. Data were collected prospectively and analyzed by two radiologists in agreement modality. Evaluation criteria were vascular involvement, resectability, and a characterization benign vs malignant. Results were compared to histopathology in 78 patients. Sixteen patients were followed-up. In 74 of 94 patients a solid tumor or an inflammation of the pancreas ( n=62) or the papilla ( n=12) was detected. In this group, MRI had a sensitivity of 98%, a specificity of 92%, and an accuracy of 96% in the characterization of malignant tumors. Regarding only the solid tumors, the positive predictive value of MRI was 87% with respect to resectability. Other pathologic findings included adenoma or inflammation of the duodenum ( n=5), carcinoma or benign stenosis of the choledochus duct ( n=7) and carcinoma of the gall bladder ( n=2). In 6 patients MRI did not depict any pathologic findings, and follow-up confirmed this interpretation. Magnetic resonance imaging allows a local preoperative staging in patients with suspected pancreatic tumor. Limitations, however, concern to the diagnostics of peritoneal and/or liver metastases.

Entities:  

Mesh:

Year:  2001        PMID: 11870425     DOI: 10.1007/s00330-001-1149-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  9 in total

1.  The role of MRI in pancreatic cancer.

Authors:  Philip A Robinson
Journal:  Eur Radiol       Date:  2001-10-16       Impact factor: 5.315

2.  Preoperative evaluation of pancreaticobiliary tumor using MR multi-imaging techniques.

Authors:  Liang Zhong; Lei Li; Qiu-Ying Yao
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

Review 3.  Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Domenico Tamburrino; Deniece Riviere; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-09-15

4.  Evaluation of steady state free precession imaging of the pancreas.

Authors:  Christoph U Herborn; Florian M Vogt; Thomas C Lauenstein; Mathias Goyen; Jörg F Debatin; Stefan G Ruehm
Journal:  Eur Radiol       Date:  2005-04-20       Impact factor: 5.315

Review 5.  Imaging modalities for characterising focal pancreatic lesions.

Authors:  Lawrence Mj Best; Vishal Rawji; Stephen P Pereira; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2017-04-17

6.  Groove pancreatic carcinomas: radiological and pathological findings.

Authors:  Toshifumi Gabata; Masumi Kadoya; Noboru Terayama; Junichiro Sanada; Satoshi Kobayashi; Osamu Matsui
Journal:  Eur Radiol       Date:  2002-11-19       Impact factor: 5.315

7.  Role of CT and MR in detection and staging of pancreatic adenocarcinoma.

Authors:  Isaac R Francis
Journal:  Cancer Imaging       Date:  2003-10-01       Impact factor: 3.909

Review 8.  [MRI for malignant pancreatic tumors].

Authors:  J Gaa; A A Fingerle; K Holzapfel; E J Rummeny
Journal:  Radiologe       Date:  2009-02       Impact factor: 0.635

Review 9.  Mangan-enhanced MR imaging for the detection and localisation of small pancreatic insulinoma.

Authors:  Ayman Kara Hamoud; M Fawad Khan; Naserdin Aboalmaali; Klaus-Henning Usadel; Christoph Wullstein; Thomas J Vogl
Journal:  Eur Radiol       Date:  2003-09-03       Impact factor: 5.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.